American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MarketAxess Holdings
MKTX
|
+$239M |
| 2 |
Eli Lilly
LLY
|
+$204M |
| 3 |
Duke Energy
DUK
|
+$179M |
| 4 |
Colgate-Palmolive
CL
|
+$178M |
| 5 |
Labcorp
LH
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$265M |
| 2 |
Emerson Electric
EMR
|
+$236M |
| 3 |
Quest Diagnostics
DGX
|
+$200M |
| 4 |
Aflac
AFL
|
+$139M |
| 5 |
ServiceNow
NOW
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.47% |
| 2 | Financials | 15.64% |
| 3 | Healthcare | 15.07% |
| 4 | Consumer Discretionary | 10.54% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Scholar Rock
SRRK
$6.67B
| $94.2K | ﹤0.01% |
+10,408
| New | +$83.5K |
|
|
PNT
2402
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $94K | ﹤0.01% |
12,898
+1,247
| +11% | +$9.25K |
|
2403
Five Point Holdings
FPH
$374M
| $93.7K | ﹤0.01% |
40,212
+2,800
| +7% | +$6.34K |
|
2404
Bionano Genomics
BNGO
$13.2M
| $93.3K | ﹤0.01% |
107
+48
| +81% | +$60.4K |
|
2405
Aldeyra Therapeutics
ALDX
$91.7M
| $91.7K | ﹤0.01% |
+13,169
| New | +$75.3K |
|
|
PAYA
2406
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $90.7K | ﹤0.01% |
+11,525
| New | +$88.9K |
|
|
KEEL
2407
Keel Infrastructure Corp
KEEL
$2.14B
| $89.7K | ﹤0.01% |
+217,000
| New | +$160K |
|
2408
Daktronics
DAKT
$1B
| $88.6K | ﹤0.01% |
31,412
-22,832
| -42% | -$70.2K |
|
2409
Gevo
GEVO
$403M
| $88.2K | ﹤0.01% |
46,412
+11,283
| +32% | +$23.8K |
|
2410
OraSure Technologies
OSUR
$267M
| $87.6K | ﹤0.01% |
+18,167
| New | +$83.3K |
|
2411
MannKind Corp
MNKD
$1.21B
| $87.1K | ﹤0.01% |
16,529
+2,424
| +17% | +$9.92K |
|
|
KZR
2412
DELISTED
Kezar Life Sciences
KZR
| $86.5K | ﹤0.01% |
+1,228
| New | +$91.1K |
|
2413
Culp Inc
CULP
$43.9M
| $85.3K | ﹤0.01% |
18,579
-5,012
| -21% | -$23.7K |
|
2414
Caribou Biosciences
CRBU
$165M
| $84.3K | ﹤0.01% |
+13,430
| New | +$119K |
|
2415
BridgeBio Pharma
BBIO
$16.2B
| $83.6K | ﹤0.01% |
10,970
-325,456
| -97% | -$3.12M |
|
2416
Atea Pharmaceuticals
AVIR
$426M
| $83.5K | ﹤0.01% |
17,363
+1,756
| +11% | +$8.88K |
|
2417
Century Aluminum
CENX
$4.88B
| $83.5K | ﹤0.01% |
10,208
-38,854
| -79% | -$293K |
|
2418
iHeartMedia
IHRT
$467M
| $83.3K | ﹤0.01% |
+13,594
| New | +$105K |
|
2419
Nektar Therapeutics
NKTR
$2.59B
| $83.3K | ﹤0.01% |
2,456
+1,339
| +120% | +$64.8K |
|
|
NIU
2420
Niu Technologies
NIU
$168M
| $79.6K | ﹤0.01% |
+15,223
| New | +$58.5K |
|
2421
MasterBrand
MBC
$1.91B
| $78K | ﹤0.01% |
+10,326
| New | +$84.6K |
|
2422
Inovio Pharmaceuticals
INO
$89.9M
| $77K | ﹤0.01% |
4,111
+2,356
| +134% | +$53.4K |
|
2423
Ardagh Metal Packaging
AMBP
$3.11B
| $75.5K | ﹤0.01% |
15,695
+377
| +2% | +$1.73K |
|
2424
Butterfly Network
BFLY
$2.48B
| $75.2K | ﹤0.01% |
30,577
+12,969
| +74% | +$46.5K |
|
2425
Seer Inc
SEER
$118M
| $74.8K | ﹤0.01% |
+12,902
| New | +$87.1K |
|
Similar funds
American Century Companies's Q4 2022 Portfolio in Review
As of Q4 2022, American Century Companies held 2,650 positions worth $122B, up 7.7% from $114B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
American Century Companies's Q4 2022 filing shows 220 new, 1,560 increased, 662 reduced and 73 closed positions. Its largest new stake was NextEra Energy, Inc. 6.926% Corporate Units: 903,403 shares worth $45.5M. The largest sale was Alphabet (Google) Class A, an estimated $265M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2022 buy was NextEra Energy, Inc. 6.926% Corporate Units: 903,403 shares worth $45.5M.
- American Century Companies added most to MarketAxess Holdings in Q4 2022, an estimated $239M increase.
- American Century Companies's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $265M.
- American Century Companies fully exited Abiomed Inc in Q4 2022, selling an estimated $96.8M.
- American Century Companies's ten largest holdings make up 19% of its $122B portfolio in Q4 2022.
- American Century Companies opened 220 new positions and closed 73 in Q4 2022.
- American Century Companies's portfolio value rose 7.7% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q4 2022, filed 13 Feb 2023.